论文信息 - First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors - 字舞流文

First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors

D. McNeel | R. Leidner | R. Wesolowski | A. Wang-Gillam | Lang Ho Lee | George N Pavlakis | Kevin Conlon | Sumati Gupta | Monica Chaudhari | Nadia Hassounah | Jong Bong Lee | Jessica A O'Keeffe | Nancy Lewis | John A Thompson